{"created":"2023-05-15T11:20:49.670104+00:00","id":3912,"links":{},"metadata":{"_buckets":{"deposit":"f9125305-69d9-406b-b29e-be41a0beece2"},"_deposit":{"created_by":1,"id":"3912","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"3912"},"status":"published"},"_oai":{"id":"oai:ir.jikei.ac.jp:00003912","sets":["25:51:204:214"]},"author_link":["48014","47999","48019","20951","48004","48017","47996","48005","46408","48008","47997","48012","48006","48010","39571","53322","16825","48011","967","48015"],"item_16_alternative_title_1":{"attribute_name":"タイトル･ヨミ","attribute_value_mlt":[{"subitem_alternative_title":"ヒト　スイゾウガン　サイボウカブ　ニ　オケル　メシルサンナファモスタット　ヘイヨウ　ニ　ヨル　ナブパクリタキセル　+　エンサンゲムシタビン　リョウホウ　ノ　NF-κB　カッセイカ　ノ　ヨクセイ　コウシュヨウコウカ　ゾウキョウ　ノ　ケントウ　ダイ131カイ　セイイカイ　ソウカイ　イッパン　エンダイ"}]},"item_16_alternative_title_3":{"attribute_name":"別タイトル","attribute_value_mlt":[{"subitem_alternative_title":"Nafamostat mesilate suppresses nuclear factor κB activation and enhances the antitumor effect of gemcitabine plus nab-paclitaxel therapy for pancreatic cancer"}]},"item_16_biblio_info_27":{"attribute_name":"雑誌名","attribute_value_mlt":[{"bibliographicIssueNumber":"6","bibliographicPageEnd":"228","bibliographicPageStart":"228","bibliographicVolumeNumber":"129","bibliographic_titles":[{"bibliographic_title":"東京慈恵会医科大学雑誌"}]}]},"item_16_date_20":{"attribute_name":"刊行年月","attribute_value_mlt":[{"subitem_date_issued_datetime":"2014-11-15","subitem_date_issued_type":"Issued"}]},"item_16_relation_28":{"attribute_name":"情報源","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"The Jikei University School of Medicine"}]}]},"item_16_rights_31":{"attribute_name":"著作権関連情報","attribute_value_mlt":[{"subitem_rights":"The Jikei University School of Medicine"}]},"item_16_select_22":{"attribute_name":"国立情報学研究所 メタデータ主題語彙集（資源タイプ）","attribute_value_mlt":[{"subitem_select_item":"Article"}]},"item_16_source_id_25":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0375-9172","subitem_source_identifier_type":"ISSN"}]},"item_16_source_id_26":{"attribute_name":"書誌レコードID（総合目録DB）","attribute_value_mlt":[{"subitem_source_identifier":"AN0016049X","subitem_source_identifier_type":"NCID"}]},"item_16_text_16":{"attribute_name":"著者所属","attribute_value_mlt":[{"subitem_text_value":"東京慈恵会医科大学医学部医学科4年"},{"subitem_text_value":"東京慈恵会医科大学附属病院肝胆膵外科"},{"subitem_text_value":"東京慈恵会医科大学附属病院肝胆膵外科"},{"subitem_text_value":"東京慈恵会医科大学附属病院肝胆膵外科"},{"subitem_text_value":"東京慈恵会医科大学附属病院肝胆膵外科"},{"subitem_text_value":"東京慈恵会医科大学附属病院肝胆膵外科"},{"subitem_text_value":"東京慈恵会医科大学附属病院肝胆膵外科"},{"subitem_text_value":"東京慈恵会医科大学総合医科学研究センター遺伝子治療研究部"},{"subitem_text_value":"東京慈恵会医科大学附属病院肝胆膵外科"}]},"item_16_version_type_44":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_be7fb7dd8ff6fe43","subitem_version_type":"NA"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"丹治, 芳明"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"堀内, 尭"}],"nameIdentifiers":[{}]},{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":""}],"affiliationNames":[{"affiliationName":""}]}],"creatorNames":[{"creatorName":"白井, 祥睦","creatorNameLang":"ja"},{"creatorName":"シライ, ヨシヒロ","creatorNameLang":"ja-Kana"},{"creatorName":"Shirai, Yoshihiro","creatorNameLang":"en"}],"familyNames":[{},{},{}],"givenNames":[{},{},{}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"岩瀬, 亮太"}],"nameIdentifiers":[{}]},{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":""}],"affiliationNames":[{"affiliationName":""}]}],"creatorNames":[{"creatorName":"古川, 賢英","creatorNameLang":"ja"},{"creatorName":"フルカワ, ケンエイ","creatorNameLang":"ja-Kana"},{"creatorName":"Furukawa, Kenei","creatorNameLang":"en"}],"familyNames":[{},{},{}],"givenNames":[{},{},{}],"nameIdentifiers":[{}]},{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":""}],"affiliationNames":[{"affiliationName":""}]}],"creatorNames":[{"creatorName":"柴, 浩明","creatorNameLang":"ja"},{"creatorName":"シバ, ヒロアキ","creatorNameLang":"ja-Kana"},{"creatorName":"Shiba, Hiroaki","creatorNameLang":"en"}],"familyNames":[{},{},{}],"givenNames":[{},{},{}],"nameIdentifiers":[{}]},{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":""}],"affiliationNames":[{"affiliationName":""}]}],"creatorNames":[{"creatorName":"宇和川, 匡","creatorNameLang":"ja"},{"creatorName":"ウワガワ, タダシ","creatorNameLang":"ja-Kana"},{"creatorName":"Uwagawa, Tadashi","creatorNameLang":"en"}],"familyNames":[{},{},{}],"givenNames":[{},{},{}],"nameIdentifiers":[{}]},{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":""}],"affiliationNames":[{"affiliationName":""}]}],"creatorNames":[{"creatorName":"大橋, 十也","creatorNameLang":"ja"},{"creatorName":"オオハシ, トウヤ","creatorNameLang":"ja-Kana"},{"creatorName":"Ohashi, Toya","creatorNameLang":"en"}],"familyNames":[{},{},{}],"givenNames":[{},{},{}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"矢永, 勝彦"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-07-02"}],"displaytype":"detail","filename":"129-6-199.pdf","filesize":[{"value":"1.4 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"129-6-199.pdf","url":"https://ir.jikei.ac.jp/record/3912/files/129-6-199.pdf"},"version_id":"5a418380-f9c5-4e5f-9093-14ec6c8c2c90"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"ヒト膵臓癌細胞株におけるメシル酸ナファモスタット併用によるナブパクリタキセル+塩酸ゲムシタビン療法のNF-κB活性化の抑制、抗腫瘍効果増強の検討 (第131回成医会総会一般演題)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"ヒト膵臓癌細胞株におけるメシル酸ナファモスタット併用によるナブパクリタキセル+塩酸ゲムシタビン療法のNF-κB活性化の抑制、抗腫瘍効果増強の検討 (第131回成医会総会一般演題)"},{"subitem_title":"ヒト膵臓癌細胞株におけるメシル酸ナファモスタット併用によるナブパクリタキセル+塩酸ゲムシタビン療法のNF-κB活性化の抑制、抗腫瘍効果増強の検討 (第131回成医会総会一般演題)","subitem_title_language":"en"}]},"item_type_id":"16","owner":"1","path":["214"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-01-27"},"publish_date":"2015-01-27","publish_status":"0","recid":"3912","relation_version_is_last":true,"title":["ヒト膵臓癌細胞株におけるメシル酸ナファモスタット併用によるナブパクリタキセル+塩酸ゲムシタビン療法のNF-κB活性化の抑制、抗腫瘍効果増強の検討 (第131回成医会総会一般演題)"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2024-02-16T04:54:59.377394+00:00"}